The Impact of 6MP Metabolite Levels on Infliximab Pharmacokinetics and Anti-infliximab Antibodies in Crohn's Disease

NCT02453607 · clinicaltrials.gov ↗

UNKNOWN

Status

225

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Bowel Disease
Crohn's Disease

Interventions

DRUG: Infliximab
DRUG: thiopurine

Sponsor

Ernest Seidman

Collaborators

[object Object]
[object Object]
[object Object]